Clinical Trial

Shanghai Lymphoma Clinical Cohort

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to prospectively collect clinical information on patients with lymphoma, and to explore the best therapeutic strategies in the real-world population.
Trial Details
NCT Number NCT07285174
Lead Sponsor Ruijin Hospital
Conditions Lymphoma, Cohort
Enrollment 1,000 participants
Start Date 2025-12-18
Primary Completion 2027-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-16